ICICI Prudential Mutual Fund
← All mutual funds

ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth

ICICI Prudential Mutual Fund · Index Funds · Direct · Growth

NAV · as of 11/09/2026

20.55

1D

-0.09%

1Y

+19.52%

Key stats

Expense ratio
0.48%
AUM
₹147.90 Cr
Launched
15/12/2022
Fund manager
Nishit Patel; Ashwini Bharucha; Venus Ahuja
Portfolio turnover
0.32%
Risk
Very High Risk
Min lump-sum
₹1,000
Min SIP
₹1,000/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth

13/08/2026 to 11/09/2026

O - H - L -

21.0620.3813/08/202611/09/2026
1W+0.19%
1M-0.89%
3M+8.97%
6M+16.34%
1Y+19.52%
3Y+20.13%
MAX+106.67%

Top holdings

22 disclosed
  • 1.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    21.31%
  • 2.

    Divi's Laboratories Ltd

    Healthcare

    9.04%
  • 3.

    Dr Reddy's Laboratories Ltd

    Healthcare

    8.94%
  • 4.

    Cipla Ltd

    Healthcare

    8.91%
  • 5.

    Laurus Labs Ltd

    Healthcare

    6.38%
  • 6.

    Lupin Ltd

    Healthcare

    6.35%
  • 7.

    Torrent Pharmaceuticals Ltd

    Healthcare

    5.24%
  • 8.

    Aurobindo Pharma Ltd

    Healthcare

    4.72%
  • 9.

    Glenmark Pharmaceuticals Ltd

    Healthcare

    3.59%
  • 10.

    Alkem Laboratories Ltd

    Healthcare

    3.52%
  • 11.

    Biocon Ltd

    Healthcare

    3.23%
  • 12.

    Mankind Pharma Ltd

    Healthcare

    3.12%
  • 13.

    Zydus Lifesciences Ltd

    Healthcare

    3.01%
  • 14.

    Ipca Laboratories Ltd

    Healthcare

    2.55%
  • 15.

    Gland Pharma Ltd

    Healthcare

    2.15%
  • 16.

    J.B. Chemicals & Pharmaceuticals Ltd

    Healthcare

    2.03%
  • 17.

    Wockhardt Ltd

    Healthcare

    1.73%
  • 18.

    Ajanta Pharma Ltd

    Healthcare

    1.56%
  • 19.

    Abbott India Ltd

    Healthcare

    1.43%
  • 20.

    Piramal Pharma Ltd

    Healthcare

    1.13%
  • 21.

    Treps

    0.66%
  • 22.

    Net Current Assets

    0.61%

Sector allocation

  • Healthcare99.94%
  • Unclassified1.27%

Comparable peers

  • ICICI Prudential Nifty Pharma Index Growth Direct Plan

    ICICI Pru Nifty Pharma Index (G) · ₹147.90 Cr AUM

    1Y+21.17%
    3Y+20.55%
    -

  • Kotak Nifty Smallcap 50 Index Growth Direct Plan

    Kotak Nifty Smallcap 50 Index (G) · ₹229.00 Cr AUM

    1Y+17.41%
    3Y+19.19%
    -

  • UTI Nifty 500 Value 50 Index Growth Direct Plan

    UTI Nifty 500 Value 50 Index (G) · ₹846.20 Cr AUM

    1Y+14.63%
    3Y+21.95%
    -

  • Motilal Oswal BSE Enhanced Value Index Growth Direct Plan

    Motilal Oswal BSE Enhanced Value Index (G) · ₹2.22 K Cr AUM

    1Y+10.12%
    3Y+20.25%
    -

  • ICICI Prudential Nifty Auto Index Growth Direct Plan

    ICICI Pru Nifty Auto Index (G) · ₹242.30 Cr AUM

    1Y+2.42%
    3Y+20.30%
    -

Investment objective

The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.

Scheme details

Scheme code
150930
Fund house
ICICI Prudential Mutual Fund
Category
Open Ended
Type
Other Scheme
Sub-category
Index Funds
Plan
Direct
Return type
Growth
ISIN (Growth)
INF109KC11M9
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page